Figure 4.
BLOC-2 interacts with the exocyst complex, which is essential for WPB biogenesis. (A) IPs of HUVEC lysates with anti-HPS6 (i) or EXOC4 (ii) antibodies resolved by SDS-PAGE and immunoblotted with HPS6 and EXOC4 antibodies. HUVEC lysate (∼5% of IP) used as input and IP with polyclonal IgG used as a control for both immunoblots. (B) IF analyses of EXOC4-depleted and control HUVECs labeled with anti-VWF antibody and counterstained with DAPI. As for BLOC-2–depleted cells, only rounded, immature WPBs, which are clumped perinuclearly are evident, highlighted by insets. Scale bars represent 10 μm. (C) Fifteen BLOC-2–depleted and control cells were randomly selected and total number of WPBs > 1.5 μM in length were determined for 2 independent studies (***P < .001). (D) EXOC4-depleted and control HUVECs dual labeled with anti-VWF and CD63 antibodies were analyzed by IF, counterstained with DAPI. The insets highlight colabeling of mature WPBs and CD63 in control cells, absent in EXOC4-depleted cells. Scale bars represent 10 μm. (E) GFP-CD63–expressing HUVECs analyzed by IF 48 hours after transfection with control or EXOC4 siRNA. Arrows show GFP-CD63 labeling of mature WPBs in control cells (i), absent in EXOC4-depleted cells (ii). Inset highlights mature WPBs. Scale bars represent 10 μm. (F) EM analyses of EXOC4-depleted HUVECs show immature WPBs with unfurled VWF (arrows). Scale bars represent 500 nm (i and iii) and 100 nm (ii and iv).

BLOC-2 interacts with the exocyst complex, which is essential for WPB biogenesis. (A) IPs of HUVEC lysates with anti-HPS6 (i) or EXOC4 (ii) antibodies resolved by SDS-PAGE and immunoblotted with HPS6 and EXOC4 antibodies. HUVEC lysate (∼5% of IP) used as input and IP with polyclonal IgG used as a control for both immunoblots. (B) IF analyses of EXOC4-depleted and control HUVECs labeled with anti-VWF antibody and counterstained with DAPI. As for BLOC-2–depleted cells, only rounded, immature WPBs, which are clumped perinuclearly are evident, highlighted by insets. Scale bars represent 10 μm. (C) Fifteen BLOC-2–depleted and control cells were randomly selected and total number of WPBs > 1.5 μM in length were determined for 2 independent studies (***P < .001). (D) EXOC4-depleted and control HUVECs dual labeled with anti-VWF and CD63 antibodies were analyzed by IF, counterstained with DAPI. The insets highlight colabeling of mature WPBs and CD63 in control cells, absent in EXOC4-depleted cells. Scale bars represent 10 μm. (E) GFP-CD63–expressing HUVECs analyzed by IF 48 hours after transfection with control or EXOC4 siRNA. Arrows show GFP-CD63 labeling of mature WPBs in control cells (i), absent in EXOC4-depleted cells (ii). Inset highlights mature WPBs. Scale bars represent 10 μm. (F) EM analyses of EXOC4-depleted HUVECs show immature WPBs with unfurled VWF (arrows). Scale bars represent 500 nm (i and iii) and 100 nm (ii and iv).

Close Modal

or Create an Account

Close Modal
Close Modal